Global Forklift Attachments Market Expected to Accumulate USD 248 Billion by 2033, Growing at 14.0% CAGR | Future Market Insights, Inc.
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
Questex’s Broadband Nation Expo Unites Industry and Government Leaders to Bring Broadband to Every Home in America
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
Questex’s Broadband Nation Expo Unites Industry and Government Leaders to Bring Broadband to Every Home in America
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
Food Wrap Films Market Size Anticipated to Surpass USD 12.0 Billion by 2026 with 2.0% CAGR Growth | Transparency Market Research, Inc.
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
Food Wrap Films Market Size Anticipated to Surpass USD 12.0 Billion by 2026 with 2.0% CAGR Growth | Transparency Market Research, Inc.
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
WellSpan’s tiniest patients celebrate their first Halloween safely and inspire early learning
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
WellSpan’s tiniest patients celebrate their first Halloween safely and inspire early learning
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
MEF Reports Significant Momentum in LSO API Adoption and Innovation
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
PowerPlan Promotes Senior Executives to Continue Driving Growth
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
Metal Replacement Market to Reach 408.32 Billion By 2032 Growing CAGR at 9.3% | Introspective Market Research
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
Life Extension and Weston FC Announce New Sponsorship
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
MEF’s Enterprise Leadership Council Triples in Size, Driving Key Initiatives in Service Automation, Cybersecurity, and AI-Ops
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
Big Idea Ventures Announces Six New Investments Through Global Food Innovation Fund II
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
ATTENTION NYSE: TD INVESTORS: Contact Berger Montague About a Toronto-Dominion Bank Class Action Lawsuit
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
15 Leading Technology and Service Providers Achieve SASE Certification in Industry’s Only Independent Certification Program
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
DigiKey to Highlight Automation Offerings and Services at SPS 2024
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
AutoScheduler Adds Vice President of Customer Success to Reinforce Focus on Successful Customer Implementations
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
MEF Releases 2025 NaaS Industry Blueprint to Accelerate Innovation Across Automated Ecosystem
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
STARCROSSED NOCTURNE is a Modern Vampire Romance Set in Dublin That Will Sharpen Your Fangs For Danger, Ancient Secrets, and Delicious Spice
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
Eagle Bancorp Montana Earns $2.7 Million, or $0.34 per Diluted Share, in the Third Quarter of 2024; Declares Quarterly Cash Dividend of $0.1425 Per Share
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
Coach K talks teamwork, communication and trust as Work Truck Week® 2025 keynote speaker
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
Latitude Food Allergy Care Announces the Opening of its New San Ramon Clinic
San Ramon, CA, Oct. 29, 2024 (GLOBE NEWSWIRE) — Latitude Food Allergy Care, the leading network of clinics providing life-changing testing and treatment to help families with food allergies live more freely, has announced...
Glycolic Acid Market Expected to Surpass USD 683.5 million by 2031, with a 7.23% CAGR – Analysis by Transparency Market Research, Inc.
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Oct. 29, 2024 (GLOBE NEWSWIRE) — The market valuation of the Global glycolic acid market (글리콜산 시장) was measured in 2021, which accounted for about...
Kepler Group Hires Industry Leader Chris O’Brien as EVP, Head of Client Solutions
NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) — Kepler Group today announced the appointment of Chris O’Brien as Executive Vice President, Head of Client Solutions. In this new role, O’Brien will report to Remy...
Walkie Stackers Market to hit $5 Bn by 2032, Says Global Market Insights Inc.
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
Charlesbank Named to Inc.’s Annual Founder-Friendly Investors List
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
E-Fuel Market to exceed $76.1 Bn by 2032, Says Global Market Insights Inc.
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
NKGen Biotech Presents Phase 1/2a Troculeucel Data in Alzheimer’s Disease at the 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
Bridger Aerospace Announces Schedule for its Third Quarter 2024 Earnings Release and Conference Call
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
Grace Expands Polypropylene Operating Capacity in India with Nayara Energy Limited
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
Franklin Electric Reports Third Quarter 2024 Results
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow
Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
IRVINE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced the pricing of its underwritten offering of (i) 18,356,173 shares of its common stock at a price of...
Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine
– First two out of three subjects treated with tegoprubart as part of immunosuppression regimen to prevent transplant rejection achieved insulin independence and remain insulin free, with glucose control in the normal range; Third...
Plus Therapeutics Showcases Leptomeningeal Metastases Programs at the 2024 SNO Annual Meeting in Houston, Texas
Company will present results from the ReSPECT-LM Phase 1 clinical trial of Rhenium (186Re) Obisbemeda for leptomeningeal metastases (LM) and discuss its plan for continued clinical development Company will present results from the FORESEE...
Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration
CLEVELAND, Oct. 29, 2024 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that the Company has resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA or Agency)...
23andMe Appoints Three New Independent Directors to Board
SUNNYVALE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), a leading human genetics and preventive health company, today announced the appointments of Andre Fernandez, Jim Frankola,...
DT Midstream Reports Strong Third Quarter 2024 Results; Raises Adjusted EBITDA Guidance
DETROIT, Oct. 29, 2024 (GLOBE NEWSWIRE) — DT Midstream, Inc. (NYSE: DTM) today announced third quarter 2024 reported net income of $88 million, or $0.90 per diluted share. For the third quarter of 2024,...
Cornerstone Financing announces $285 million financing from Aquiline and Nomura
BLOOMFIELD, N.J., Oct. 29, 2024 (GLOBE NEWSWIRE) — Cornerstone Financing, an insurance and investment funding company, has secured $285 million in aggregate financing through global finance investment firms Aquiline Capital Partners LP (“Aquiline”) and...
Streamline Health® Adds Quality Module to Third eValuator™ Client
ATLANTA, Oct. 29, 2024 (GLOBE NEWSWIRE) — – Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has expanded its relationship...
Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences
BOSTON, Oct. 29, 2024 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that the Company will...
H&E Rentals Reports Third Quarter 2024 Results
BATON ROUGE, La., Oct. 29, 2024 (GLOBE NEWSWIRE) — H&E Equipment Services, Inc. (NASDAQ: HEES) (“H&E”, the “Company”, d/b/a “H&E Rentals”) today reported financial results for the third quarter ended September 30, 2024. The report...
Invivyd Reports Preliminary Third Quarter 2024 Results, Withdraws Prior Financial Guidance, and Targets Near-Term Profitability
Preliminary Q3 2024 PEMGARDA™ (pemivibart) net product revenue of $9.3 million; Invivyd ended Q3 2024 with approximately $107 million in cash and cash equivalents Expects to finish 2024 with $65 million or more in...
Invivyd Phase 3 Long-Term Exploratory Clinical Efficacy Data Shows PEMGARDA™ (pemivibart) Provided Substantial Protection from Symptomatic COVID-19 Versus Placebo Over Six Months of Follow-Up, With No Additional Doses, In Immunocompetent Participants
Following strong protection (84% relative risk reduction versus placebo) demonstrated through month 6 with pemivibart, CANOPY clinical trial participants were followed for an additional six-month period (months 7-12), with no additional doses, to assess...
Macerich Refinances Top-Performing Queens Center at Favorable Terms
5.37% Fixed Rate for 5 Years, Interest Only, on $525M Loan Lowest Refi Rate Achieved by Company in Past 5 Years SANTA MONICA, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) — Macerich (NYSE: MAC), one...
Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now
MIAMI, Oct. 29, 2024 (GLOBE NEWSWIRE) — EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 76th Emerging Growth Conference on October 30 & 31, 2024. The Emerging Growth Conference...
BioXcel Therapeutics to Present at ThinkEquity Conference
NEW HAVEN, Conn., Oct. 29, 2024 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that Vimal Mehta, Ph.D., CEO, and...
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Iris Energy Limited (NASDAQ:IREN) Investors to Contact the Firm
SAN FRANCISCO, Oct. 29, 2024 (GLOBE NEWSWIRE) — Girard Sharp, LLP, a national investment, securities, and class action firm, announces an investigation on behalf of investors who purchased or otherwise acquired Iris Energy securities....
2ONE Labs Receives PMTA ‘Acceptance’ for 2ONE® Nicotine Pouch brand from FDA Center for Tobacco Products
LAKE TAHOE, Nev., Oct. 29, 2024 (GLOBE NEWSWIRE) — 2ONE Labs Inc., is pleased to announce the ‘Acceptance’ of its Premarket Tobacco Product Application (PMTA) submission by the U.S. Food and Drug Administration for its...
Sagimet Biosciences Announces Successful Completion of End-of-Phase 2 Interactions with FDA on the Development of Denifanstat for MASH; Phase 3 Program Initiation Expected by End of 2024
The planned registration program consists of two double-blind, placebo-controlled multicenter Phase 3 trials, FASCINATE-3 and FASCINIT, to evaluate the safety and efficacy of denifanstat in patients with MASH and MASLD SAN MATEO, Calif., Oct....
Bitterroot Bio Completes Enrollment in Phase 1 First-in-Human Study of BRB-002 in Healthy Volunteers
PALO ALTO, Calif. and NEEDHAM, Mass. and MELBOURNE, Australia, Oct. 29, 2024 (GLOBE NEWSWIRE) — Bitterroot Bio, a leader in developing innovative medicines in the field of cardio-immunology, today announced the completion of enrollment...